Business
Press Release Jun 28 2024
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 28, 2024, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Doxycycline Capsules, 40 mg".
About this update from Alembic Pharmaceuticals Limited
[{"type":"text","content":" Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 28, 2024, titled \"Alembic Pharmaceuticals receives USFDA Final Approval for Doxycycline Capsules, 40 mg\". View Attachment","length":382,"tagName":"div"}]